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Background: Hepatic injury in dengue virus (DENV) infection is authenticated by hepatomegaly and an upsurge in
transaminase levels. DENV replicates in hepatocytes and causes hepatocyte apoptosis both in vitro and in vivo.
Understanding the molecular mechanisms of DENV-induced hepatic injury could facilitate the development of
alternate chemotherapeutic agents and improved therapies.
Findings: The p38 mitogen-activated protein kinase (MAPK) participates in both apoptosis-related signaling and
pro- inflammatory cytokine production. The role of p38 MAPK in DENV-infected HepG2 cells was examined using
RNA interference. The results showed that DENV infection activated p38 MAPK and induced apoptosis. The p38
MAPK activation and TNF-α production were controlled by p38 MAPK and CD137 signaling in DENV-infected
HepG2 cells as activated p38 MAPK, TNF-α and apoptosis were significantly decreased in p38 MAPK and CD137
depleted DENV-infected HepG2 cells. Addition of exogenous TNF-α to p38 MAPK depleted DENV-infected HepG2
cells restored DENV-induced apoptosis in HepG2 cells.
Conclusion: DENV induces CD137 signaling to enhance apoptosis by increasing TNF-α production via activation of
p38 MAPK.
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Hepatic dysfunction is a crucial feature of DENV infec-
tion. Hepatic biopsy specimens obtained from fatal cases
of dengue shock syndrome (DSS) show cellular apoptosis,
which may relate to the pathogenesis of DSS [1,2]. DENV
replicates in hepatocytes and apoptosis of DENV-infected
hepatic cells has been observed both in vitro and in vivo.
Both the cell death receptor and the mitochondrial apop-
totic pathways are affected [3-9].
DENV capsid protein (DENV C) activates both extrin-
sic and intrinsic apoptotic pathways in hepatic cell lines* Correspondence: thawornchai.lim@mahidol.ac.th
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reproduction in any medium, provided the or[10-12]. DENV C localizes to both the cytoplasm and
nucleus of DENV-infected HepG2 cells. DENV C contains
three nuclear localization signals (NLS), 6KKAR9,
73KKSK76 and the bipartite signal 85RKeigrmlnilnRRRR100.
Substitution mutations in DENV C (R85A/K86A) result
in loss of nuclear localization, Daxx interaction, and
apoptosis [11]. Comparison of the apoptotic gene ex-
pression profile of DENV C and DENV C (R85A/K86A)
transfected HepG2 cells showed a significant increase in
expression of CD137, a member of TNF receptor family,
in HepG2 cells expressing DENV C. In DENV-infected
HepG2 cells, CD137 and CD137 ligand mRNA expression
increased 60-fold and 3-fold post DENV infection, re-
spectively. CD137 positive cells increased, but less dramat-
ically, about 3-fold post infection and correlates with the
level of apoptosis induced by DENV infection of HepG2
cells, which increased 4-fold post DENV infection [13].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(TRAF2) and activates apoptosis signal regulating kinase 1
(ASK1), resulting in activation of cJun N-terminal kinase
(JNK) and p38 mitogen-activated protein kinase (MAPK)
[14]. p38 MAPK is primarily implicated in apoptosis-
related signaling [15]. However, activation of p38 MAPK
increases inflammatory cytokine production [16]. Activa-
tion of p38 MAPK may contribute to the pathogenesis of
DENV-induced apoptosis via both mechanisms.
Inhibition of DENV-induced apoptosis in HepG2 cells by
siRNA against p38 MAPK
We first asked whether RNAi knockdown of p38α MAPK,
which is a crucial mediator of proinflammatory cytokine
production, would inhibit DENV-induced apoptosis in
HepG2 cells, an approach that might alleviate DENV-
mediated hepatic injury. At 24 h after seeding, HepG2







































DENV + sip38 MAPK
Figure 1 Decreased apoptosis in p38 MAPK knockdown DENV-infecte
directed against p38 MAPK or with control siRNA. Twenty-four hours post t
were harvested and analyzed for (A) mRNA level of p38 MAPK (B) protein l
have annexin V+/PI- staining. (D) Bar graph represents apoptosis experimen
reported as the mean ± SEM. Statistical differences between the groups we
P value less than 0.05 was considered significant.against p38α MAPK, 50CAGACCATATTAACCAGCTTC
AGCA30 or with siControl, 50 CACGCCTCTTTGTCTT
GTTTCGAAA 30 (Invitrogen), using lipofectamine 2000
(Invitrogen). Twenty-four hours post transfection, the cells
were infected with DENV serotype 2 strain 16681 at an
MOI of 5 using the methods described previously [13].
The percentage of apoptotic cells was determined by
annexin V/FITC and PI double staining (BD Biosciences)
and quantitation by flow cytometry. The efficiency of
p38α MAPK knockdown by siRNA was examined by real-
time RT-PCR using p38α MAPK-specific primers (p38α
MAPK-F, 50CGACTTGCTGGAGAAGATGC30, and p38α
MAPK-R, 50TCCATCTCTTCTTGGTCAAGG30) and by
Western blot analysis using primary antibodies against
p38 MAPK and β-actin (Santa Cruz Biotechnology).
About 30% decreases in both mRNA and protein expres-
sion levels of p38 MAPK were observed (Figure 1A, 1B).
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http://www.virologyj.com/content/10/1/105reduced apoptosis from 23.43% to 16.53% in DENV-
infected HepG2 cells (Figure 1C, D) suggesting a role for
p38 MAPK in DENV-mediated apoptosis. The result of
siRNA directed against p38 MAPK in DENV-infected
HepG2 cells is agreeable to our previous study of pharma-
cological inhibition of p38 MAPK by SB203580 in DENV-
infected HepG2 cells [17]. Therefore, genetic inhibition of
p38 activity reproduces pharmacological inhibition of the
enzyme and confirms the contribution of p38 MAPK to
apoptotic events induced by DENV [17]. DENV infected
HepG2 cells equally in the presence or absence of
SB203580 [17] but DENV production in BHK-21 cells was
decreased in the presence of SB203580 [18].
Inhibition of DENV C-induced apoptosis in stable HepG2
cell expressing DENV C by siRNA against p38 MAPK
We next asked whether DENV C activates p38 MAPK-
induced apoptosis by examining the effect of siRNA
against p38α MAPK on apoptosis of HepG2 cells stably
expressing DENV C. HepG2 cells stably expressing
DENV C were constructed in this study using retroviral(A) (B)DENV C + 
siControl































Figure 2 Decreased apoptosis in p38 MAPK knockdown HepG2 cells e
plasmid were transfected either with siRNA directed against p38 MAPK or w
1 ug/ml cycloheximide for 24 h. Cells were collected and analyzed for (A) p
experiments. All data were obtained from three independent experiments
groups were tested with an unpaired t-test using StatView version 5.0 and
flow cytometry.system (Stratagene). Briefly, 70% confluent of HEK
293T cells was transfected with p-VPack-GP, p-VPack-
VSV-G and pFB-Neo-DENV C using lipofectamine
2000 (Invitrogen). The culture supernatant containing
infectious viral particles was collected after 24 h post
transfection and added to HepG2 cells, which were pre-
incubated with 8 μg / ml of polybrene. Twenty-four h
after incubation, stable HepG2 cells expressing DENV C
were selected with media containing 0.5 mg/ml G418
(Calbiochem). The G418-resistant cells were grown and
maintained in DMEM medium containing 0.5 mg/ml
G418, and the expression of DENV C was examined by
flow cytometry and Western blot analysis using anti-
body to DENV C [19]. Up to 5 × 105 the stably express-
ing cells were plated for 24 h prior to transfection. The
cells were then transfected with siRNAs as described in
the preceding experiment. Knock-down efficiency was
assessed by Western blot analysis. The 15 kDa capsid
protein was expressed in stable HepG2 cells expressing
DENV but not in HepG2 cells expressing control plas-
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and reported as the mean ± SEM. Statistical differences between the
P value less than 0.05 was considered significant. (C) Apoptosis by
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http://www.virologyj.com/content/10/1/105pathway, cells were treated with 0.5 μg/ml anti-Fas mAb
(Sigma) and 1 ug/ml cycloheximide (Sigma) for 24 h in
culture medium. Both adherent and floating cells, as well
as culture supernatants, were collected and assessed for
apoptosis by annexinV/PI staining (BD Biosciences). As
with DENV-infected cells, siRNA p38α MAPK resulted in
a substantial reduction in p38 MAPK protein, but had no
effect on DENV C expression (Figure 2A). In the presence
of anti-Fas and cycloheximide, apoptosis of HepG2 cells
expressing DENV C increased from 7.79% to 32.83% com-
pared to that of HepG2 cells expressing control plasmid.
HepG2 cells expressing DENV C transfected with p38
MAPK siRNA reduced apoptosis from 32.83% to 23%
(Figure 2B, 2C). In our previous study without anti-Fas
mAb and cycloheximide treatment, HepG2 cells were
transiently transfected with a DENV C or control plasmid
and incubated in the presence of DMSO or 10 μM of
SB203580 for 24 h. The percentage of apoptotic cells
was then determined by annexin V/FITC and PI double
staining and quantitation by flow cytometry. Compar-
able to apoptosis of HepG2 cells expressing control
plasmid, apoptosis of HepG2 cells expressing DENV C
increased from 10.11% to 24.40%. Apoptosis of HepG2
cells expressing DENV C decreased from 24.40% to 5.69%
in medium with SB203580 [17]. Therefore, genetic inhib-
ition of p38 activity reproduces pharmacological inhibition
of the enzyme and verifies the contribution of p38 MAPK
to apoptotic events induced specifically by DENV C. How-
ever, not all DENV-induced cell death is caused by DENV
C, other DENV proteins including M, NS3 protease and
NS2B-NS3 precursor also induces apoptosis [20,21].
Inhibition of DENV-induced phosphorylated p38 MAPK,
TNF-α production and apoptosis in HepG2 cells by siRNA
against CD137
To further define the molecular mechanisms involved,
we asked whether CD137 signaling regulates p38 MAPK
activation and apoptosis in DENV-infected HepG2 cells.
siRNA knockdown of CD137 was performed as de-
scribed for p38 MAPK using the CD137-specific oligo
50CACGCTCCGTTTCTCTGTTGTTAAA 30 (Invitrogen).
The efficiency of knockdown was examined by real-time
RT-PCR using CD137-specific primers CD137-F, 50CCA
AAA TGT TCT GCT GAT CG30 and CD137-R, 50 AAG
ACT GTG GCG CCC TG30. The number of CD 137 posi-
tive cells was measured by flow cytometry using a primary
antibody against CD137 (Santa Cruz Biotechnology).
Transfection of HepG2 cells with siRNA against CD137
resulted in a nearly 2-fold reduction in CD137 mRNA and
CD137-positive cells (Figure 3A, 3B). The effect of CD137
depletion on p38 MAPK activation during DENV
infection and apoptosis were measured by Western blot
analysis using primary antibody against phosphorylated
p38 MAPK (Santa Cruz Biotechnology), and by annexinV/PI staining (BD Biosciences), respectively. Knockdown of
CD137 expression reduced the amount of phosphorylated
p38 MAPK (Figure 3C) and apoptosis (Figure 3D). These
results indicate a role of CD137 signaling in regulation of
p38 MAPK activation and apoptosis in DENV-infected
HepG2 cells. As DENV induced CD137 expression only
30% of the infected cells (Figure 3B) and expressed at the
late stage of infection [13], CD137 and p38 MAPK signal-
ing may support other apoptotic signaling pathways [3-9]
to aggravate apoptosis at the late stage of DENV infection.
Multiple studies in vitro and in vivo models implicate
TNF-α in DENV-induced tissue damage [8,22]. In
addition, TNF-α induced apoptosis via p38 MAPK activa-
tion was shown in pseudorabies virus infection [23].
We next asked whether TNF-α mediated DENV-
induced apoptosis via CD137 signaling. TNF-α expres-
sion in CD137 depleted DENV-infected HepG2 cells was
examined by real-time RT-PCR using TNF-α-specific
primers TNF-α-F, 50TGCTTGTTCCTCAGCCTCTT30,and
TNF-α-R, 50 ATGGGCTACAGGCTTGTCACT30 and
by ELISA (R&D Systems). DENV infection of HepG2
cells resulted in a dramatic increase in TNF-α mRNA
and protein (Figure 3E, 3F). However, CD137 siRNA
treatment reduced of TNF-α production about 30%
(Figure 3E, 3F), which correlates well with the compar-
able reduction in apoptosis of CD137 knockdown cells
(Figure 3D).
Inhibition of p38 MAPK activity by SB203580 decreased
TNF-α production in DENV-infected HepG2 cells
As p38 MAPK is one of the downstream targets of CD137
signaling, it is important to assess whether inhibition of
p38 MAPK activity in DENV-infected HepG2 cells would
reduce TNF-α expression. HepG2 cells were infected with
DENV serotype 2 at a MOI 5 and incubated 48 h in the
presence of either DMSO or 10 μM SB203580 (Santa
Cruz Biotechnology). TNF-α mRNA expression of DENV-
infected HepG2 cells and TNF-α protein expression in
supernatant of DENV-infected HepG2 cells were subse-
quently examined by real-time RT-PCR and by ELISA, re-
spectively. As expected, treatment with 10 μM SB203580
significantly reduced TNF-α expression in DENV-infected
HepG2 cells (Figure 4A, 4B) indicating that pharmaco-
logical inhibition of p38 MAPK reduced TNF-α secretion
in DENV-infected HepG2 cells. Whether inhibition of
both p38 and CD137 signalings has the additive effect on
TNF-α production merits further investigation.
The role of TNF-α expression in apoptosis of DENV-
infected HepG2 cells
It would be important to evaluate the effect of TNF-α
expression in apoptosis of DENV-infected HepG2 cells.
Supernatants containing DENV from mock-infected or
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Figure 3 Reduced DENV-induced phosphorylated p38 MAPK, TNF-α and apoptosis in HepG2 cells by siRNA against CD137. HepG2 cells
were transfected with either CD137 siRNA or control siRNA. Twenty-four hours post transfection, cells were infected with DENV at MOI 5 for 60 h.
Cells were collected and analyzed for (A) CD137 mRNA (B) CD137 positive cells (C) phosphorylation of p38 and (D) Apoptosis by flow cytometry.
The cells were collected and analyzed for TNF-α mRNA (E) and the culture supernatant was analyzed for TNF-α protein (F). All data were obtained
from three independent experiments and reported as the mean ± SEM. Statistical differences between the groups were tested with an unpaired
t-test using StatView version 5.0 and P value less than 0.05 was considered significant.
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Figure 4 Reduced DENV-induced TNF-α production and apoptosis in SB203580 treated DENV-infected HepG2 cells and exogenous
TNF-α restored the apoptosis. (A) HepG2 cells were infected with DENV serotype 2 at a MOI 5 and incubated 48 h in the presence of either
DMSO or 10 μM SB203580. TNF-α mRNA (A) and TNF-α protein (B) expression of DENV-infected HepG2 cells was subsequently examined by real-
time RT-PCR and by ELISA, respectively. All data were obtained from three independent experiments and reported as the mean ± SEM. Statistical
differences between the groups were tested with an unpaired t-test using StatView version 5.0 and P value less than 0.05 was considered
significant. (C) Supernatants containing DENV from mock-infected or DENV-infected HepG2 cells in the presence of either DMSO or 10 μM
SB203580 was isolated and incubated with HepG2 cells in the presence or absence of recombinant TNF-α. The percentage of apoptotic cells was
then determined at 72 h by annexin V/FITC and PI double staining and quantitation by flow cytometry. Apoptosis cells have annexin V+/PI-
staining. (D) Model representing the augmentation of DENV-induced apoptosis mediated by TNF-α via the activation of p38 MAPK and
CD137 signaling.
Nagila et al. Virology Journal 2013, 10:105 Page 6 of 7
http://www.virologyj.com/content/10/1/105DMSO or 10 μM SB203580 was isolated and further
incubated with HepG2 cells in the presence or absence
of recombinant TNF-α (250 ng/ml)(Sigma). The
percentage of apoptotic cells was then determined at
72 h by annexin V/FITC and PI double staining and
quantitation by flow cytometry. The result in Figure 4C
showed that apoptosis of DENV-infected HepG2 cells
decreased from 22% to 11.59% when HepG2 cells were
incubated with supernatant containing virus from
SB203580 treated DENV-infected HepG2 cells. Ad-
dition of recombinant TNF-α to supernatant from
SB203580 treated DENV-infected HepG2 cells in-
creased apoptosis of DENV-infected HepG2 cells from
11.59% to 17.89% (Figure 4C) suggesting that TNF-α
production affects DENV-induced apoptosis of HepG2cells. Our result supports the previous studies for the
role of TNF-α expression in DENV-induced apoptosis
in other cell lines. TNF-α produced from macrophage
was shown to enhance DENV-induced endothelial cell
death [24] and inhibition of peripheral blood mono-
nuclear cell (PBMC) apoptosis by etanercept, which is
the antibody to TNF-α, was also reported [25]. In sum-
mary, we propose in Figure 4D that DENV induces
phosphorylated p38 MAPK to stimulate apoptosis and
inhibition of p38 MAPK and CD137 pathway reduce
DENV-induced TNF-α secretion and apoptosis of
HepG2 cells.Competing interests
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